"Hyperbilirubinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.
| Descriptor ID |
D006932
|
| MeSH Number(s) |
C23.550.429
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperbilirubinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperbilirubinemia".
This graph shows the total number of publications written about "Hyperbilirubinemia" by people in this website by year, and whether "Hyperbilirubinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperbilirubinemia" by people in Profiles.
-
Ablation of high-mobility group box-1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling-deficient mice. Hepatol Commun. 2022 08; 6(8):2155-2169.
-
Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leuk Lymphoma. 2018 10; 59(10):2360-2368.
-
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. Clin Pharmacol Ther. 2016 Apr; 99(4):363-9.
-
Index of suspicion. Pediatr Rev. 2014 Feb; 35(2):88-93.
-
Spur cell anemia as a cause of unconjugated hyperbilirubinemia after liver transplantation and its resolution after retransplantation. Liver Transpl. 2011 Mar; 17(3):349-50.
-
Bilirubin impairs intestinal regrowth following massive small bowel resection in a rat model. J Pediatr Gastroenterol Nutr. 2009 Jul; 49(1):16-22.
-
Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates. Clin Chim Acta. 2006 Mar; 365(1-2):177-82.
-
A novel approach to the management of late-onset liver failure in biliary atresia. J Pediatr Surg. 2004 Mar; 39(3):371-4.
-
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003 Jul; 143(1):16-25.
-
Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients. Transplantation. 2000 May 15; 69(9):1882-6.